2002
DOI: 10.1016/s0021-9150(02)00234-4
|View full text |Cite
|
Sign up to set email alerts
|

Soluble intercellular adhesion molecule-1 is related to endothelial vasodilatory function in healthy individuals

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

8
23
2
1

Year Published

2004
2004
2024
2024

Publication Types

Select...
7
1

Relationship

0
8

Authors

Journals

citations
Cited by 42 publications
(34 citation statements)
references
References 28 publications
8
23
2
1
Order By: Relevance
“…Similarly conflicting results have been published for other hemostatic and inflammatory proteins measured in our study (protein C, factor , thrombomodulin, hsCRP) 10,11,[17][18][19][20][21][22][23][24] . There are, as highlighted in the "Introduction", important differences in the design of our study as compared to the studies mentioned above.…”
Section: Discussioncontrasting
confidence: 73%
“…Similarly conflicting results have been published for other hemostatic and inflammatory proteins measured in our study (protein C, factor , thrombomodulin, hsCRP) 10,11,[17][18][19][20][21][22][23][24] . There are, as highlighted in the "Introduction", important differences in the design of our study as compared to the studies mentioned above.…”
Section: Discussioncontrasting
confidence: 73%
“…Although many prior studies suggest an association of endothelial dysfunction with risk of type 2 diabetes, the data are limited by cross-sectional study designs or limited ability to fully control for confounding factors (8 -18). The present data build on prior data to demonstrate that elevated levels of these biomarkers of endothelial dysfunction are significant, independent precursors of type 2 diabetes in the community Endothelial dysfunction reflects an imbalance in the regulatory function of vascular endothelial cells and is characterized by impaired endothelium-dependent nitric oxide-mediated vasodilatation (28), elevated plasma levels of cellular adhesion molecules (11,29), microalbuminuria (30), and impaired fibrinolysis, marked by elevated plasma levels of PAI-1 and vWF (31). The primary physiologic function of PAI-1 and vWF is to maintain hemostatic balance in the vasculature (32,33), but because the endothelium is a primary source of PAI-1 and vWF, elevated levels also reflect stimulation or injury of endothelial cells (32,34).…”
Section: Diabetes Vol 55 February 2006supporting
confidence: 61%
“…The primary physiologic function of PAI-1 and vWF is to maintain hemostatic balance in the vasculature (32,33), but because the endothelium is a primary source of PAI-1 and vWF, elevated levels also reflect stimulation or injury of endothelial cells (32,34). Elevated plasma levels of biomarkers of endothelial dysfunction are modestly correlated with impaired endothelium-dependent vasodilatation in forearm skin or the brachial artery (11,29) and are highly correlated with insulin resistance (12,35,36), providing one mechanism by which endothelial dysfunction might confer risk for type 2 diabetes. In the arteriolar microcirculation, impaired endothelium-dependent vasomotion may limit insulin-mediated capillary recruitment and redistribution of skeletal muscle blood flow from nonnutritive to nutritive flow routes, diminishing insulin delivery to insulin-sensitive muscle tissue (6,(37)(38)(39).…”
Section: Diabetes Vol 55 February 2006mentioning
confidence: 99%
“…An increase in severity (stage) of hypertension was not associated with a change in the expression of the 2 CAMs. This observation is, at least in part, consistent with those in the study by Preston et al,31 in which the strong positive correlation between slCAM-1, sVCAM-1, and vWF levels versus BP in patients with normotension or mild hypertension was not found in patients with severe hypertension (mean SBP/DBP, 195 [26]/127 [7] mm Hg). The mechanisms by which systemic hypertension leads to an increase in levels of particular CAMs is not fully understood.…”
Section: Discussionsupporting
confidence: 91%
“…[14][15][16][17][18][19] However, controversy exists as to whether individuals with hypertension without other risk factors for atherosclerosis have elevated levels of CAMs. 16,[20][21][22][23][24] Moreover, even in population-based studies, the relationships between CAMs and blood pressure (BP) are inconsistent) 9, [25][26][27] The aim of this study was to determine whether (1) levels of sCAMs (sE-selectin, slCAM-1, sVCAM-1, and von Willebrand factor [vWF]) are elevated in Taiwanese adults with uncomplicated essential hypertension without other risk factors; (2) CAM levels increase with severity (stage) of hypertension; and (3) monotherapy with the angiotensin II-receptor blocker (ARB) irbesartan modulates CAM expression in a subgroup of these patients.…”
Section: Introductionmentioning
confidence: 99%